Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2000 Jan;76(891):4–11. doi: 10.1136/pmj.76.891.4

Hepatocellular carcinoma

S Badvie 1
PMCID: PMC1741466  PMID: 10622772

Abstract

Primary hepatocellular carcinoma is one of the 10 most common tumours, and the most common primary liver malignancy, in the world. In the majority of cases, it occurs against a background of hepatitis B or C viral infection and/or liver cirrhosis, and is associated with a dismal prognosis of a few months. Current treatments in routine clinical practice are surgical resection and liver transplantation, but these therapies are applicable to only a small proportion of patients and prolongation of survival is restricted. Other treatment options include intra-arterial chemotherapy, transcatheter arterial chemoembolisation, percutaneous ethanol injection, cryotherapy, thermotherapy, proton therapy, or a wide range of their possible combinations. The current lack of definitive data, however, limits the use of these therapies. Another option is gene therapy, which although in its infancy at the present time, may have a significant role to play in the future management of hepatocellular carcinoma.


Keywords: hepatocellular carcinoma; hepatic resection; liver transplantation; transcatheter arterial chemoembolisation

Full Text

The Full Text of this article is available as a PDF (1.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter M. J., Moyer L. A. The importance of preventing hepatitis C virus infection among injection drug users in the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 (Suppl 1):S6–10. doi: 10.1097/00042560-199802001-00003. [DOI] [PubMed] [Google Scholar]
  2. Bartolozzi C., Lencioni R., Armillotta N. Trattamento combinato dell'epatocarcinoma con chemioembolizzazione e alcoolizzazione. Risultati a lungo termine. Radiol Med. 1997 Jul-Aug;94(1-2):19–23. [PubMed] [Google Scholar]
  3. Bartolozzi C., Lencioni R., Caramella D., Palla A., Bassi A. M., Di Candio G. Small hepatocellular carcinoma. Detection with US, CT, MR imaging, DSA, and Lipiodol-CT. Acta Radiol. 1996 Jan;37(1):69–74. doi: 10.1177/02841851960371P114. [DOI] [PubMed] [Google Scholar]
  4. Belli L., Magistretti G., Puricelli G. P., Damiani G., Colombo E., Cornalba G. P. Arteritis following intra-arterial chemotherapy for liver tumors. Eur Radiol. 1997;7(3):323–326. doi: 10.1007/s003300050159. [DOI] [PubMed] [Google Scholar]
  5. Bismuth H., Chiche L., Adam R., Castaing D., Diamond T., Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993 Aug;218(2):145–151. doi: 10.1097/00000658-199308000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bismuth H., Morino M., Sherlock D., Castaing D., Miglietta C., Cauquil P., Roche A. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 1992 Apr;163(4):387–394. doi: 10.1016/0002-9610(92)90039-t. [DOI] [PubMed] [Google Scholar]
  7. Bolondi L., Gaiani S., Benzi G., Zironi G., Rigamonti A., Fusconi F., Barbara L. Ultrasonography and guided biopsy in the diagnosis of hepatocellular carcinoma. Ital J Gastroenterol. 1992 Jan;24(1):46–49. [PubMed] [Google Scholar]
  8. Born M., Layer G., Kreft B., Schwarz N., Schild H. MRT, CT und CTAP in der Diagnostik maligner Lebertumoren bei Leberzirrhose. Rofo. 1998 Jun;168(6):567–572. doi: 10.1055/s-2007-1015282. [DOI] [PubMed] [Google Scholar]
  9. Carr B. I., Zajko A., Bron K., Orons P., Sammon J., Baron R. Phase II study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: interim analysis. Semin Oncol. 1997 Apr;24(2 Suppl 6):S6–97-S6-99. [PubMed] [Google Scholar]
  10. Castells A., Bruix J., Bru C., Fuster J., Vilana R., Navasa M., Ayuso C., Boix L., Visa J., Rodés J. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology. 1993 Nov;18(5):1121–1126. [PubMed] [Google Scholar]
  11. Castells A., Bruix J., Brú C., Ayuso C., Roca M., Boix L., Vilana R., Rodés J. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology. 1995 Sep;109(3):917–922. doi: 10.1016/0016-5085(95)90402-6. [DOI] [PubMed] [Google Scholar]
  12. Ch Yu S., Metreweli C., Lau W. Y., Leung W. T., Liew C. T., Leung N. W. Safety of percutaneous biopsy of hepatocellular carcinoma with an 18 gauge automated needle. Clin Radiol. 1997 Dec;52(12):907–911. doi: 10.1016/s0009-9260(97)80222-x. [DOI] [PubMed] [Google Scholar]
  13. Chang M. H. Hepatitis B: long-term outcome and benefits from mass vaccination in children. Acta Gastroenterol Belg. 1998 Apr-Jun;61(2):210–213. [PubMed] [Google Scholar]
  14. Chao Y., Chan W. K., Huang Y. S., Teng H. C., Wang S. S., Lui W. Y., Whang-Peng J., Lee S. D. Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer. 1996 Feb 15;77(4):635–639. [PubMed] [Google Scholar]
  15. Chen H. S., Gross J. F. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep. 1980 Jan;64(1):31–40. [PubMed] [Google Scholar]
  16. Cheng A. L., Chen Y. C., Yeh K. H., Chuang S. E., Chen B. R., Chen D. S. Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma. Cancer. 1996 Mar 1;77(5):872–877. [PubMed] [Google Scholar]
  17. Chlebowski R. T., Brzechwa-Adjukiewicz A., Cowden A., Block J. B., Tong M., Chan K. K. Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results. Cancer Treat Rep. 1984 Mar;68(3):487–491. [PubMed] [Google Scholar]
  18. Colleoni M., Audisio R. A., De Braud F., Fazio N., Martinelli G., Goldhirsch A. Practical considerations in the treatment of hepatocellular carcinoma. Drugs. 1998 Mar;55(3):367–382. doi: 10.2165/00003495-199855030-00004. [DOI] [PubMed] [Google Scholar]
  19. Colleoni M., Gaion F., Liessi G., Mastropasqua G., Nelli P., Manente P. Medical treatment of hepatocellular carcinoma: any progress? Tumori. 1994 Oct 31;80(5):315–326. doi: 10.1177/030089169408000501. [DOI] [PubMed] [Google Scholar]
  20. Dalgic A., Mirza D. F., Gunson B. K., D'Silva M., Mayer A. D., Buckels J. A., McMaster P. Role of total hepatectomy and transplantation in hepatocellular carcinoma. Transplant Proc. 1994 Dec;26(6):3564–3565. [PubMed] [Google Scholar]
  21. Dalla Palma L., Pozzi-Mucelli R. S. Computed tomography and magnetic resonance imaging in diagnosing hepatocellular carcinoma. Ital J Gastroenterol. 1992 Feb;24(2):87–91. [PubMed] [Google Scholar]
  22. Di Stasi M., Buscarini L., Livraghi T., Giorgio A., Salmi A., De Sio I., Brunello F., Solmi L., Caturelli E., Magnolfi F. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol. 1997 Nov;32(11):1168–1173. doi: 10.3109/00365529709002998. [DOI] [PubMed] [Google Scholar]
  23. Doci R., Bignami P., Bozzetti F., Bonfanti G., Audisio R., Colombo M., Gennari L. Intrahepatic chemotherapy for unresectable hepatocellular carcinoma. Cancer. 1988 May 15;61(10):1983–1987. doi: 10.1002/1097-0142(19880515)61:10<1983::aid-cncr2820611009>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  24. Duvoux C. Epidémiologie et diagnostic des carcinomes hépatocellulaires sur cirrhose. Ann Chir. 1998;52(6):511–517. [PubMed] [Google Scholar]
  25. Ellis P. A., Norman A., Hill A., O'Brien M. E., Nicolson M., Hickish T., Cunningham D. Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours. Eur J Cancer. 1995 Sep;31A(10):1594–1598. doi: 10.1016/0959-8049(95)00323-b. [DOI] [PubMed] [Google Scholar]
  26. Falkson G., Ansell S. Phase II trial of buserelin in hepatocellular carcinoma. Eur J Cancer Clin Oncol. 1989 Sep;25(9):1339–1340. doi: 10.1016/0277-5379(89)90083-7. [DOI] [PubMed] [Google Scholar]
  27. Falkson G., Moertel C. G., Lavin P., Pretorius F. J., Carbone P. P. Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial. Cancer. 1978 Nov;42(5):2149–2156. doi: 10.1002/1097-0142(197811)42:5<2149::aid-cncr2820420510>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  28. Farmer D. G., Rosove M. H., Shaked A., Busuttil R. W. Current treatment modalities for hepatocellular carcinoma. Ann Surg. 1994 Mar;219(3):236–247. doi: 10.1097/00000658-199403000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ferry N. La thérapie génique des cancers primitifs du foie: espoirs et réalités. Bull Cancer. 1997 Apr;84(4):431–434. [PubMed] [Google Scholar]
  30. Funovics J. M., Fritsch A., Herbst F., Piza F., Mühlbacher F., Längle F., Schemper M. Primary hepatic cancer--the role of limited resection and total hepatectomy with orthotopic liver replacement. Hepatogastroenterology. 1988 Dec;35(6):316–320. [PubMed] [Google Scholar]
  31. Gugenheim J., Baldini E., Casaccia M., Ouzan D., Saint-Paul M. C., Mouiel J. Résection et transplantation hépatique pour carcinome hépatocellulaire chez les malades atteints de cirrhose. Gastroenterol Clin Biol. 1997;21(8-9):590–595. [PubMed] [Google Scholar]
  32. Hashimoto M., Watanabe O., Hirano Y., Kato K., Watarai J. Use of carbon dioxide microbubble-enhanced sonographic angiography for transcatheter arterial chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol. 1997 Nov;169(5):1307–1310. doi: 10.2214/ajr.169.5.9353447. [DOI] [PubMed] [Google Scholar]
  33. Hsu S. L., Lin H. M., Chou C. K. Suppression of the tumorigenicity of human hepatoma hep3B cells by long-term retinoic acid treatment. Cancer Lett. 1996 Jan 19;99(1):79–85. doi: 10.1016/0304-3835(95)04040-4. [DOI] [PubMed] [Google Scholar]
  34. Huang H., Chen S. H., Kosai K., Finegold M. J., Woo S. L. Gene therapy for hepatocellular carcinoma: long-term remission of primary and metastatic tumors in mice by interleukin-2 gene therapy in vivo. Gene Ther. 1996 Nov;3(11):980–987. [PubMed] [Google Scholar]
  35. Hytiroglou P., Theise N. D. Differential diagnosis of hepatocellular nodular lesions. Semin Diagn Pathol. 1998 Nov;15(4):285–299. [PubMed] [Google Scholar]
  36. Ito K., Honjo K., Fujita T., Awaya H., Matsumoto T., Matsunaga N., Higuchi M., Kada T., Mattrey R. F. Liver neoplasms: diagnostic pitfalls in cross-sectional imaging. Radiographics. 1996 Mar;16(2):273–293. doi: 10.1148/radiographics.16.2.8966286. [DOI] [PubMed] [Google Scholar]
  37. Izumi R., Shimizu K., Iyobe T., Ii T., Yagi M., Matsui O., Nonomura A., Miyazaki I. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology. 1994 Aug;20(2):295–301. [PubMed] [Google Scholar]
  38. Johnson R. C. Hepatocellular carcinoma. Hepatogastroenterology. 1997 Jan-Feb;44(13):307–312. [PubMed] [Google Scholar]
  39. Jourdan J. L., Stubbs R. S. Percutaneous biopsy of operable liver lesions: is it necessary or advisable? N Z Med J. 1996 Dec 13;109(1035):469–470. [PubMed] [Google Scholar]
  40. Kaczynski J., Hansson G., Remotti H., Wallerstedt S. Spontaneous regression of hepatocellular carcinoma. Histopathology. 1998 Feb;32(2):147–150. doi: 10.1046/j.1365-2559.1998.00340.x. [DOI] [PubMed] [Google Scholar]
  41. Kanematsu M., Hoshi H., Murakami T., Inaba Y., Kim T., Yamada T., Kato M., Yokoyama R., Nakamura H. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. AJR Am J Roentgenol. 1997 Dec;169(6):1507–1515. doi: 10.2214/ajr.169.6.9393154. [DOI] [PubMed] [Google Scholar]
  42. Kanematsu T., Furuta T., Takenaka K., Matsumata T., Yoshida Y., Nishizaki T., Hasuo K., Sugimachi K. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology. 1989 Jul;10(1):98–102. doi: 10.1002/hep.1840100119. [DOI] [PubMed] [Google Scholar]
  43. Kinami Y., Takashima S., Tanaka T., Arizuka S., Ashida Y., Miyazaki I. [Intra-arterial continuous infusion in patients with advanced and recurrent cancer of the digestive system]. Gan To Kagaku Ryoho. 1985 Oct;12(10):1990–1998. [PubMed] [Google Scholar]
  44. Kouroumalis E., Skordilis P., Thermos K., Vasilaki A., Moschandrea J., Manousos O. N. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut. 1998 Mar;42(3):442–447. doi: 10.1136/gut.42.3.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lai C. L., Wu P. C., Chan G. C., Lok A. S., Lin H. J. Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer. 1988 Aug 1;62(3):479–483. doi: 10.1002/1097-0142(19880801)62:3<479::aid-cncr2820620306>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  46. Lai C. L., Wu P. C., Lok A. S., Lin H. J., Ngan H., Lau J. Y., Chung H. T., Ng M. M., Yeoh E. K., Arnold M. Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial. Br J Cancer. 1989 Dec;60(6):928–933. doi: 10.1038/bjc.1989.392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Lau W. Y., Leung W. T., Ho S., Leung N. W., Chan M., Lin J., Metreweli C., Johnson P., Li A. K. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer. 1994 Nov;70(5):994–999. doi: 10.1038/bjc.1994.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Leung W. T., Lau W. Y., Ho S., Chan M., Leung N., Lin J., Ho K. C., Metreweli C., Johnson P. J., Li A. K. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma. J Nucl Med. 1994 Aug;35(8):1313–1318. [PubMed] [Google Scholar]
  49. Lin D. Y., Lin S. M., Liaw Y. F. Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997 Oct;12(9-10):S319–S328. doi: 10.1111/j.1440-1746.1997.tb00516.x. [DOI] [PubMed] [Google Scholar]
  50. Liu C. L., Ngan H., Lo C. M., Fan S. T. Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization. Br J Surg. 1998 Apr;85(4):512–514. doi: 10.1046/j.1365-2168.1998.00664.x. [DOI] [PubMed] [Google Scholar]
  51. Livraghi T., Bolondi L., Lazzaroni S., Marin G., Morabito A., Rapaccini G. L., Salmi A., Torzilli G. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer. 1992 Feb 15;69(4):925–929. doi: 10.1002/1097-0142(19920215)69:4<925::aid-cncr2820690415>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  52. Lygidakis N. J., Pothoulakis J., Konstantinidou A. E., Spanos H. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study. Anticancer Res. 1995 Mar-Apr;15(2):543–550. [PubMed] [Google Scholar]
  53. Manesis E. K., Giannoulis G., Zoumboulis P., Vafiadou I., Hadziyannis S. J. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial. Hepatology. 1995 Jun;21(6):1535–1542. [PubMed] [Google Scholar]
  54. Martínez Cerezo F. J., Tomás A., Donoso L., Enríquez J., Guarner C., Balanzó J., Martínez Nogueras A., Vilardell F. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma. J Hepatol. 1994 Jun;20(6):702–706. doi: 10.1016/s0168-8278(05)80138-2. [DOI] [PubMed] [Google Scholar]
  55. Matsushiro Y., Ebara M., Ohto M., Kondo F. [Usefulness of percutaneous biopsy under sonographic control and histological examination in the early diagnosis of hepatocellular carcinoma]. Nihon Shokakibyo Gakkai Zasshi. 1993 Mar;90(3):655–664. [PubMed] [Google Scholar]
  56. Matsuzaki Y., Osuga T., Chiba T., Saito Y., Tanaka N., Itai Y., Tsujii H. New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma. Intern Med. 1995 Apr;34(4):302–304. doi: 10.2169/internalmedicine.34.302. [DOI] [PubMed] [Google Scholar]
  57. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., Montalto F., Ammatuna M., Morabito A., Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996 Mar 14;334(11):693–699. doi: 10.1056/NEJM199603143341104. [DOI] [PubMed] [Google Scholar]
  58. Moreno González E., Gómez R., García I., González-Pinto I., Loinaz C., Ibañez J., Bercedo J., Palomo J. C., Palma F., Vorwald P. Liver transplantation in malignant primary hepatic neoplasms. Am J Surg. 1992 Apr;163(4):395–400. doi: 10.1016/0002-9610(92)90040-x. [DOI] [PubMed] [Google Scholar]
  59. Motohashi I., Okudaira M., Takai T., Kaneko S., Ikeda N. Morphological differences between hepatocellular carcinoma and hepatocellular carcinomalike lesions. Hepatology. 1992 Jul;16(1):118–126. doi: 10.1002/hep.1840160120. [DOI] [PubMed] [Google Scholar]
  60. Nagasue N., Kohno H., Uchida M. Evaluation of preoperative transcatheter arterial embolization in the treatment of resectable primary liver cancer. Semin Surg Oncol. 1993 Jul-Aug;9(4):327–331. doi: 10.1002/ssu.2980090409. [DOI] [PubMed] [Google Scholar]
  61. Nagasue N., Yukaya H., Ogawa Y., Sasaki Y., Chang Y. C., Niimi K. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery. 1986 Jun;99(6):694–701. [PubMed] [Google Scholar]
  62. Nakashima O., Kojiro M. [Pathomorphologic characteristics and differential diagnosis of small hepatocellular carcinoma]. Gan To Kagaku Ryoho. 1996 Jun;23(7):827–834. [PubMed] [Google Scholar]
  63. Nerenstone S. R., Ihde D. C., Friedman M. A. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev. 1988 Mar;15(1):1–31. doi: 10.1016/0305-7372(88)90007-2. [DOI] [PubMed] [Google Scholar]
  64. Ohnishi K., Yoshioka H., Ito S., Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology. 1998 Jan;27(1):67–72. doi: 10.1002/hep.510270112. [DOI] [PubMed] [Google Scholar]
  65. Onohara S., Kobayashi H., Itoh Y., Shinohara S. Intra-arterial cis-platinum infusion with sodium thiosulfate protection and angiotensin II induced hypertension for treatment of hepatocellular carcinoma. Acta Radiol. 1988 Mar-Apr;29(2):197–202. [PubMed] [Google Scholar]
  66. Paraskevopoulos J. A. Management options for primary hepatocellular carcinoma. An overview. Acta Oncol. 1994;33(8):895–900. doi: 10.3109/02841869409098452. [DOI] [PubMed] [Google Scholar]
  67. Patt Y. Z., Charnsangavej C., Yoffe B., Smith R., Lawrence D., Chuang V., Carrasco H., Roh M., Chase J., Fischer H. Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival. J Clin Oncol. 1994 Jun;12(6):1204–1211. doi: 10.1200/JCO.1994.12.6.1204. [DOI] [PubMed] [Google Scholar]
  68. Patt Y. Z., Yoffe B., Charnsangavej C., Pazdur R., Fischer H., Cleary K., Roh M., Smith R., Noonan C. A., Levin B. Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b. Cancer. 1993 Nov 1;72(9):2574–2582. doi: 10.1002/1097-0142(19931101)72:9<2574::aid-cncr2820720911>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  69. Pawarode A., Voravud N., Sriuranpong V., Kullavanijaya P., Patt Y. Z. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol. 1998 Aug;21(4):386–391. doi: 10.1097/00000421-199808000-00014. [DOI] [PubMed] [Google Scholar]
  70. Pichlmayr R., Weimann A., Oldhafer K. J., Schlitt H. J., Klempnauer J., Bornscheuer A., Chavan A., Schmoll E., Lang H., Tusch G. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg. 1995 Nov-Dec;19(6):807–813. doi: 10.1007/BF00299775. [DOI] [PubMed] [Google Scholar]
  71. Rummeny E. J., Marchal G. Liver imaging. Clinical applications and future perspectives. Acta Radiol. 1997 Jul;38(4 Pt 2):626–630. doi: 10.1080/02841859709172392. [DOI] [PubMed] [Google Scholar]
  72. Ryder S. D., Rizzi P. M., Metivier E., Karani J., Williams R. Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma. Gut. 1996 Jan;38(1):125–128. doi: 10.1136/gut.38.1.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Sachs E., Di Bisceglie A. M., Dusheiko G. M., Song E., Lyons S. F., Schoub B. D., Kew M. C. Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study. Br J Cancer. 1985 Jul;52(1):105–109. doi: 10.1038/bjc.1985.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Sato M., Watanabe Y., Ueda S., Iseki S., Abe Y., Sato N., Kimura S., Okubo K., Onji M. Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology. 1996 May;110(5):1507–1514. doi: 10.1053/gast.1996.v110.pm8613057. [DOI] [PubMed] [Google Scholar]
  75. Selby R., Kadry Z., Carr B., Tzakis A., Madariaga J. R., Iwatsuki S. Liver transplantation for hepatocellular carcinoma. World J Surg. 1995 Jan-Feb;19(1):53–58. doi: 10.1007/BF00316980. [DOI] [PubMed] [Google Scholar]
  76. Shepherd F. A., Evans W. K., Blackstein M. E., Fine S., Heathcote J., Langer B., Taylor B., Habal F., Kutas G., Pritchard K. I. Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma. J Clin Oncol. 1987 Apr;5(4):635–640. doi: 10.1200/JCO.1987.5.4.635. [DOI] [PubMed] [Google Scholar]
  77. Sherman M. Hepatocellular carcinoma. Gastroenterologist. 1995 Mar;3(1):55–66. [PubMed] [Google Scholar]
  78. Shiina S., Tagawa K., Unuma T., Takanashi R., Yoshiura K., Komatsu Y., Hata Y., Niwa Y., Shiratori Y., Terano A. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer. 1991 Oct 1;68(7):1524–1530. doi: 10.1002/1097-0142(19911001)68:7<1524::aid-cncr2820680711>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  79. Shimada M., Maeda T., Saitoh A., Morotomi I., Kano T. Needle track seeding after percutaneous ethanol injection therapy for small hepatocellular carcinoma. J Surg Oncol. 1995 Apr;58(4):278–281. doi: 10.1002/jso.2930580416. [DOI] [PubMed] [Google Scholar]
  80. Shimizu S., Takayama T., Kosuge T., Yamamoto J., Shimada K., Yamazaki S., Hasegawa H., Makuuchi M. Benign tumors of the liver resected because of a diagnosis of malignancy. Surg Gynecol Obstet. 1992 May;174(5):403–407. [PubMed] [Google Scholar]
  81. Snarska J., Puchalski Z., Sokołowski Z., Pruszyński K. Powikłania po zabiegach resekcyjnych miazszu watroby. Wiad Lek. 1997;50 (Suppl 1 Pt 2):284–288. [PubMed] [Google Scholar]
  82. Soga K., Nomoto M., Ichida T., Aoyagi Y., Ozaki T., Ichida F. Clinical evaluation of transcatheter arterial embolization and one-shot chemotherapy in hepatocellular carcinoma. Hepatogastroenterology. 1988 Jun;35(3):116–120. [PubMed] [Google Scholar]
  83. Soulier J. P., Gozin D., Lefrere J. J. A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma. Gastroenterology. 1986 Nov;91(5):1258–1262. doi: 10.1016/s0016-5085(86)80025-7. [DOI] [PubMed] [Google Scholar]
  84. Toyoda H., Nakano S., Kumada T., Takeda I., Sugiyama K., Osada T., Kiriyama S., Suga T., Takahashi M. The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma. Oncology. 1995 Jul-Aug;52(4):295–299. doi: 10.1159/000227477. [DOI] [PubMed] [Google Scholar]
  85. Vogl T. J., Müller P. K., Hammerstingl R., Weinhold N., Mack M. G., Philipp C., Deimling M., Beuthan J., Pegios W., Riess H. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: technique and prospective results. Radiology. 1995 Jul;196(1):257–265. doi: 10.1148/radiology.196.1.7540310. [DOI] [PubMed] [Google Scholar]
  86. Wallner I., Hartmann H., Ramadori G. Aktuelle Therapiestrategien für das hepatozelluläre Karzinom, Teil 1. Leber Magen Darm. 1994 Jul;24(4):150, 153-4. [PubMed] [Google Scholar]
  87. Wong W. S., Patel S. C., Cruz F. S., Gala K. V., Turner A. F. Cryosurgery as a treatment for advanced stage hepatocellular carcinoma: results, complications, and alcohol ablation. Cancer. 1998 Apr 1;82(7):1268–1278. doi: 10.1002/(sici)1097-0142(19980401)82:7<1268::aid-cncr9>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  88. Wu M., Chen H., Yao X. [Surgical treatment of primary liver cancer]. Zhonghua Wai Ke Za Zhi. 1996 Dec;34(12):707–710. [PubMed] [Google Scholar]
  89. Yamamoto M., Ogawa K., Morita M., Fukuda K., Komatsu Y. The herbal medicine Inchin-ko-to inhibits liver cell apoptosis induced by transforming growth factor beta 1. Hepatology. 1996 Mar;23(3):552–559. doi: 10.1053/jhep.1996.v23.pm0008617437. [DOI] [PubMed] [Google Scholar]
  90. Yamashita Y., Mitsuzaki K., Yi T., Ogata I., Nishiharu T., Urata J., Takahashi M. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology. 1996 Jul;200(1):79–84. doi: 10.1148/radiology.200.1.8657948. [DOI] [PubMed] [Google Scholar]
  91. Yamashita Y., Takahashi M., Koga Y., Saito R., Nanakawa S., Hatanaka Y., Sato N., Nakashima K., Urata J., Yoshizumi K. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer. 1991 Jan 15;67(2):385–391. doi: 10.1002/1097-0142(19910115)67:2<385::aid-cncr2820670212>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  92. Yu J. S., Kim K. W., Lee J. T., Yoo H. S. MR imaging during arterial portography for assessment of hepatocellular carcinoma: comparison with CT during arterial portography. AJR Am J Roentgenol. 1998 Jun;170(6):1501–1506. doi: 10.2214/ajr.170.6.9609162. [DOI] [PubMed] [Google Scholar]
  93. Zaniboni A., Simoncini E., Marpicati P., Marini G. Phase II study of 5-fluorouracil (5-FU) and high dose folinic acid (HDFA) in hepatocellular carcinoma. Br J Cancer. 1988 Mar;57(3):319–319. doi: 10.1038/bjc.1988.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Zhou X. D., Tang Z. Y. Management of hepatocellular carcinoma: long-term outcome in 2639 cases. Gan To Kagaku Ryoho. 1997 May;24 (Suppl 1):9–16. [PubMed] [Google Scholar]
  95. Zhou X., Tang Z., Yu Y. [Prognostic factors of primary liver cancer]. Zhonghua Nei Ke Za Zhi. 1996 Aug;35(8):527–529. [PubMed] [Google Scholar]
  96. Zibari G. B., Riche A., Zizzi H. C., McMillan R. W., Aultman D. F., Boykin K. N., Gonzalez E., Nandy I., Dies D. F., Gholson C. F. Surgical and nonsurgical management of primary and metastatic liver tumors. Am Surg. 1998 Mar;64(3):211–221. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES